Jason Aryeh bought $2,494 of OBIO
director at Orchestra BioMed Holdings, Inc.. 665 shares at an average of $3.75, traded May 18, 2026, filed May 20, 2026.
Score components
- +15RoleDirector
- 0Trade size$2k at market
- -5Relative to holdingsUnder 1% of holdings (0.6%)
- +4Price context26% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +0.3%, 3m +39.4%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-064136, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 18, 2026 | POpen-market purchase Common Stock, par value $0.0001 per share | +665 | $3.75 | $2,494 | 118,118 | May 20, 2026 |
Related signals
Other insiders at Orchestra BioMed Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $95k 15,000 shares | -1% | |
| 34Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $48k 10,000 shares | +1% | |
| 3Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $74k 15,000 shares | -1% | |
| 31Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $11k 2,000 shares | - | |
| 2Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $61k 15,000 shares | -1% | |
| 3Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $64k 15,000 shares | -1% | |
| 32Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $19k 5,000 shares | +0% | |
| 2Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $58k 15,000 shares | -1% | |
| 47Moderate | Orchestra BioMed Holdings, Inc. | Jason Aryeh director | $35k 8,971 shares | +8% | |
| 38Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $19k 5,000 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.